İ. COŞKUN BENLİDAYI Et Al. , "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.," 13th Mediterranean Congress of Physical Rehabilitation Medicine. , 2019
COŞKUN BENLİDAYI, İ. Et Al. 2019. Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.. 13th Mediterranean Congress of Physical Rehabilitation Medicine. .
COŞKUN BENLİDAYI, İ., GÖKÇEN, N., ŞEN, E. İ., GÜZEL, R., & SİNDEL, D., (2019). Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status. . 13th Mediterranean Congress of Physical Rehabilitation Medicine.
COŞKUN BENLİDAYI, İLKE Et Al. "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.," 13th Mediterranean Congress of Physical Rehabilitation Medicine., 2019
COŞKUN BENLİDAYI, İLKE C. Et Al. "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.." 13th Mediterranean Congress of Physical Rehabilitation Medicine. , 2019
COŞKUN BENLİDAYI, İ. Et Al. (2019) . "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.." 13th Mediterranean Congress of Physical Rehabilitation Medicine. .
@conferencepaper{conferencepaper, author={İLKE COŞKUN BENLİDAYI Et Al. }, title={Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.}, congress name={13th Mediterranean Congress of Physical Rehabilitation Medicine.}, city={}, country={}, year={2019}}